Product Information

TRIAMCINOLONE 0.147 MG/G SPRAY is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $2.7181 per GM under NDC 45802004502. Its NADAC has been published 331 times since Apr 20, 2016.

FDA first approved this application on Apr 13, 2015. Its Orange Book therapeutic-equivalence code is AT.

TRIAMCINOLONE 0.147 MG/G SPRAY

Triamcinolone Acetonide
$2.7181per GM

Strength

.147 mg/g

NDC

45802004502

Classification

Generic

Dosage Form

AEROSOL, SPRAY

Route

TOPICAL

Effective Date

10/21/2026

Active Ingredients

TRIAMCINOLONE ACETONIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205782

FDA Approved

4/13/2015

TE Code

AT

On Market Since

4/17/2015

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for TRIAMCINOLONE 0.147 MG/G SPRAY has been published 331 times since Apr 20, 2016, and over the history we have for it it has declined 11.9%. The table below summarizes its recorded NADAC range and movement.

Current price$2.7181 per GM
All-time high$3.1748 (Jul 15, 2026)
All-time low$1.6948 (Oct 23, 2024)
52-week high$3.1748
52-week low$2.1461
Median price$2.8307
Average price$2.6945
Largest weekly change+56.2% (Feb 19, 2025)
Weeks tracked331
Tracking sinceApr 20, 2016

Price History

1W

0.0%

1M

-4.0%

3M

-11.1%

6M

-5.1%

1Y

+25.3%

3Y

-9.9%

5Y

-4.0%

All

-11.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRIAMCINOLONE 0.147 MG/G SPRAY?

The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE 0.147 MG/G SPRAY, manufactured by Padagis Israel Pharmaceuticals Ltd, is $2.7181 per GM (NDC 45802004502), effective Nov 11, 2026.

How has the price of TRIAMCINOLONE 0.147 MG/G SPRAY changed over time?

Over the history we have for it, the NADAC for TRIAMCINOLONE 0.147 MG/G SPRAY has declined 11.9%. It has been tracked across 331 weekly CMS publications since Apr 20, 2016.

What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE 0.147 MG/G SPRAY?

Since Apr 20, 2016, the NADAC for TRIAMCINOLONE 0.147 MG/G SPRAY has ranged from a low of $1.6948 (Oct 23, 2024) to a high of $3.1748 (Jul 15, 2026), with a median of $2.8307 per GM.

Are there cheaper alternatives to TRIAMCINOLONE 0.147 MG/G SPRAY?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMCINOLONE 0.147 MG/G SPRAY, is $2.0026 per GM — about 26% below TRIAMCINOLONE 0.147 MG/G SPRAY.

Who manufactures TRIAMCINOLONE 0.147 MG/G SPRAY?

TRIAMCINOLONE 0.147 MG/G SPRAY (NDC 45802004502) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.